Financhill
Back

HealthEquity Quote, Financials, Valuation and Earnings

HealthEquity Price Quote

$94.97
+0.01 (+0.22%)
(Updated: December 21, 2024 at 5:30 AM ET)

HealthEquity Key Stats

Sell
50
HealthEquity (HQY) is a Sell

Day range:
$92.02 - $95.58
52-week range:
$64.62 - $105.82
Dividend yield:
0%
P/E ratio:
148.38
P/S ratio:
7.29
P/B ratio:
3.87%

Volume:
1.9M
Avg. volume:
873.7K
1-year change:
47.13%
Market cap:
$8.2B
Revenue:
$999.6M
EPS:
$1.09

How Much Does HealthEquity Make?

Data Unavailable

Is HealthEquity Growing As A Company?

Data Unavailable

HealthEquity Stock Price Performance

  • Did HealthEquity Stock Go Up Last Month?
    HealthEquity share price went down by -7.77% last month
  • Did HQY's Share Price Rise Over The Last Year?
    HQY share price rose by 47.13% over the past 1 year

What Is HealthEquity 52-Week High & Low?

HealthEquity Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy HealthEquity?

Data Unavailable

Is HealthEquity Cash Flow Positive?

Data Unavailable

HealthEquity Return On Invested Capital

Data Unavailable

HealthEquity Earnings Date & Stock Price

  • What Is HealthEquity's Stock Price Today?
    A single share of HQY can be purchased today for 94.96
  • What Is HealthEquity’s Stock Symbol?
    HealthEquity trades on the nasdaq under the ticker symbol: HQY
  • When Is HealthEquity’s Next Earnings Date?
    The next quarterly earnings date for HealthEquity is scheduled on March 19, 2025
  • When Is HQY's next ex-dividend date?
    HealthEquity's next ex-dividend date is May 15, 2020
  • How To Buy HealthEquity Stock?
    You can buy HealthEquity shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

HealthEquity Competitors

  • Who Are HealthEquity's Competitors?
    Below is a list of companies who compete with HealthEquity or are related in some way:
    • Accolade Inc (ACCD)
    • HealthStream Inc (HSTM)
    • Schrodinger Inc (SDGR)
    • Simulations Plus Inc (SLP)

HealthEquity Dividend Yield

Data Unavailable

HealthEquity Analyst Estimates

YoY Growth Past Surprise
EPS: -64.71% 7.99%
Revenue: 20.55% 3.6%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 113.00
Upside from Last Price: 19%

Major Shareholders

Data Unavailable